Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
205.45
209.36
188.00
177.76
181.95
159.30
145.28
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
205.45
209.36
188.00
177.76
181.95
159.30
145.28
Raw Material Cost
77.07
80.19
79.62
80.43
83.66
62.51
54.47
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
19.29
21.77
20.46
20.79
22.65
18.39
15.59
Selling and Distribution Expenses
67.24
65.55
72.70
73.74
58.65
42.07
43.34
Other Expenses
-1.93
-2.18
-2.05
-2.08
-2.27
-1.84
-1.56
Total Expenditure (Excl Depreciation)
144.31
145.74
152.32
154.17
142.31
104.58
97.81
Operating Profit (PBDIT) excl Other Income
61.1
63.6
35.699999999999996
23.599999999999998
39.6
54.699999999999996
47.5
Other Income
3.56
3.12
2.38
2.23
1.81
3.28
4.40
Operating Profit (PBDIT)
121.10
123.24
94.67
82.38
97.96
99.75
87.33
Interest
19.29
21.77
20.46
20.79
22.65
18.39
15.59
Exceptional Items
-16.37
-1.53
-0.58
-1.90
-1.53
-24.03
-7.18
Gross Profit (PBDT)
128.38
129.17
108.38
97.32
98.29
96.79
90.81
Depreciation
56.40
56.51
56.61
56.56
56.51
41.75
35.47
Profit Before Tax
29.04
43.44
17.02
3.12
17.27
15.58
29.10
Tax
12.07
11.93
5.04
0.70
4.73
6.25
9.49
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
16.96
31.51
11.98
2.42
12.54
9.34
19.61
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
16.96
31.51
11.98
2.42
12.54
9.34
19.61
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
16.96
31.51
11.98
2.42
12.54
9.34
19.61
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
301.68
274.81
232.21
234.43
228.84
234.28
216.58
Earnings per share (EPS)
0.46
0.84
0.34
0.07
0.35
0.27
0.52
Diluted Earnings per share
0.46
0.84
0.34
0.07
0.35
0.27
0.52
Operating Profit Margin (Excl OI)
29.76%
30.39%
18.98%
13.27%
21.79%
34.35%
32.68%
Gross Profit Margin
41.58%
47.74%
39.17%
33.58%
40.55%
35.99%
44.44%
PAT Margin
8.26%
15.05%
6.37%
1.36%
6.89%
5.86%
13.5%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is -1.91% vs 11.38% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is -46.03% vs 162.50% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is -2.16% vs 30.12% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is -11.47% vs 6.34% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
Compare Quarterly Results Of Collegium Pharmaceutical, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
205.45
118.05
87.40
74.04%
Other Operating Income
0.00
0.00
0.00
Total Operating income
205.45
118.05
87.40
74.04%
Raw Material Cost
77.07
42.43
34.64
81.64%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
19.29
3.31
15.98
482.78%
Selling and Distribution Expenses
67.24
32.07
35.17
109.67%
Other Expenses
-1.93
0.12
-2.05
-1,708.33%
Total Expenditure (Excl Depreciation)
144.31
79.06
65.25
82.53%
Operating Profit (PBDIT) excl Other Income
61.14
38.99
22.15
56.81%
Other Income
3.56
5.54
-1.98
-35.74%
Operating Profit (PBDIT)
121.10
54.65
66.45
121.59%
Interest
19.29
3.31
15.98
482.78%
Exceptional Items
-16.37
153.82
-170.19
-110.64%
Gross Profit (PBDT)
128.38
75.61
52.77
69.79%
Depreciation
56.40
10.12
46.28
457.31%
Profit Before Tax
29.04
195.04
-166.00
-85.11%
Tax
12.07
30.88
-18.81
-60.91%
Provisions and contingencies
0
0
0.00
Profit After Tax
16.96
164.15
-147.19
-89.67%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
16.96
164.15
-147.19
-89.67%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
16.96
164.15
-147.19
-89.67%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
301.68
1,172.84
-871.16
-74.28%
Earnings per share (EPS)
0.46
1.94
-1.48
-76.29%
Diluted Earnings per share
0.46
1.94
-1.48
-76.29%
Operating Profit Margin (Excl OI)
29.76%
33.03%
0.00
-3.27%
Gross Profit Margin
41.58%
173.80%
0.00
-132.22%
PAT Margin
8.26%
139.06%
0.00
-130.80%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 20.54 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -1.91% vs 11.38% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 12.92% vs 21.51% in Dec 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.70 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -46.03% vs 162.50% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 36.00% vs -60.82% in Dec 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.75 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -2.16% vs 30.12% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 22.14% vs -1.03% in Dec 2024
Quarterly - Interest
Interest 1.93 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -11.47% vs 6.34% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -14.98% vs 17.62% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.76%
in Dec 2025Figures in %
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
